Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Dow
Johnson and Johnson
AstraZeneca
Mallinckrodt

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Teva Pharmaceuticals International GmbH v. Lupin, Ltd. (D. Del. 2019)

See Plans and Pricing

« Back to Dashboard

Teva Pharmaceuticals International GmbH v. Lupin, Ltd. (D. Del. 2019)

Docket   Start Trial Date Filed 2019-07-02
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm F. Connolly
Jury Demand None Referred To
Parties CEPHALON, INC.; EAGLE PHARMACEUTICALS, INC.; LUPIN PHARMACEUTICALS, INC.; LUPIN, LTD.; TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Patents 10,010,533; 10,052,385; 8,609,707; 9,034,908; 9,144,568; 9,265,831; 9,572,796; 9,572,797; 9,572,887; 9,579,384; 9,597,397; 9,597,398; 9,597,399
Attorneys Deanne M. Mazzochi; Jeffrey A Marx; John W. Shaw; Karen Elizabeth Keller; Kenneth Laurence Dorsney; Kevin P. Burke; Melvin W. Gaddy; Nathan Roger Hoeschen; Paul J. Molino; William A. Rakoczy
Firms Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Teva Pharmaceuticals International GmbH v. Lupin, Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Teva Pharmaceuticals International GmbH v. Lupin, Ltd. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 4 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,609,707 B2; US 9,000,021 … 2 July 2019 1:19-cv-01251 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 5 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,572,796 B2; US 9,572,797 … 2 July 2019 1:19-cv-01251 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 6 Patent/Trademark Report to Commissioner of Patents B2; US 9,597,399 B2; US 10,010,533 B2; US 10,052,385 B2. (nmg) (Entered: 07/03/2019) 2 July 2019 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,597,398 B2… 2 July 2019 1:19-cv-01251 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.